Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Packham

Showing results (111-120 of 128) with videos related to

Pageof 13
Sort By:
Biochemical Pharmacology|July 10, 2008
Characterisation of the in vitro activity of the depsipeptide histone deacetylase inhibitor spiruchostatin ASimon J Crabb, Melanie Howell, Helen Rogers, et al.
Molecular and Cellular Biology|October 12, 2011
Inhibition of the single downstream target BAG1 activates the latent apoptotic potential of MYCXiao-Yong Zhang, Harla K Pfeiffer, Hestia S Mellert, et al.
Blood|October 23, 2015
Engagement of the B-cell receptor of chronic lymphocytic leukemia cells drives global and MYC-specific mRNA translationAlison Yeomans, Stephen M Thirdborough, Beatriz Valle-Argos, et al.
Blood|March 19, 2015
Lectins from opportunistic bacteria interact with acquired variable-region glycans of surface immunoglobulin in follicular lymphomaDunja Schneider, Marcus Dühren-von Minden, Alabbas Alkhatib, et al.
Blood|March 23, 2016
IL-4 enhances expression and function of surface IgM in CLL cellsMaria M Aguilar-Hernandez, Matthew D Blunt, Rachel Dobson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2021
Kinobead Profiling Reveals Reprogramming of BCR Signaling in Response to Therapy within Primary CLL CellsAdam J Linley, Laura I Karydis, Anil K Mondru, et al.
Blood|April 29, 2022
Characterization of metabolic alterations of chronic lymphocytic leukemia in the lymph node microenvironmentZhenghao Chen, Helga Simon-Molas, Gaspard Cretenet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2016
The Dual Syk/JAK Inhibitor Cerdulatinib Antagonizes B-cell Receptor and Microenvironmental Signaling in Chronic Lymphocytic LeukemiaMatthew D Blunt, Stefan Koehrer, Rachel C Dobson, et al.
Blood|May 10, 2015
The PI3K/mTOR inhibitor PF-04691502 induces apoptosis and inhibits microenvironmental signaling in CLL and the Eµ-TCL1 mouse modelMatthew D Blunt, Matthew J Carter, Marta Larrayoz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2018
Target-Based Screening against eIF4A1 Reveals the Marine Natural Product Elatol as a Novel Inhibitor of Translation Initiation with <i>In Vivo</i> Antitumor ActivityTara L Peters, Joseph Tillotson, Alison M Yeomans, et al.
Pageof 13

Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
Biochemical Pharmacology|July 10, 2008
Characterisation of the in vitro activity of the depsipeptide histone deacetylase inhibitor spiruchostatin ASimon J Crabb, Melanie Howell, Helen Rogers, et al.
Molecular and Cellular Biology|October 12, 2011
Inhibition of the single downstream target BAG1 activates the latent apoptotic potential of MYCXiao-Yong Zhang, Harla K Pfeiffer, Hestia S Mellert, et al.
Blood|October 23, 2015
Engagement of the B-cell receptor of chronic lymphocytic leukemia cells drives global and MYC-specific mRNA translationAlison Yeomans, Stephen M Thirdborough, Beatriz Valle-Argos, et al.
Blood|March 19, 2015
Lectins from opportunistic bacteria interact with acquired variable-region glycans of surface immunoglobulin in follicular lymphomaDunja Schneider, Marcus Dühren-von Minden, Alabbas Alkhatib, et al.
Blood|March 23, 2016
IL-4 enhances expression and function of surface IgM in CLL cellsMaria M Aguilar-Hernandez, Matthew D Blunt, Rachel Dobson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2021
Kinobead Profiling Reveals Reprogramming of BCR Signaling in Response to Therapy within Primary CLL CellsAdam J Linley, Laura I Karydis, Anil K Mondru, et al.
Blood|April 29, 2022
Characterization of metabolic alterations of chronic lymphocytic leukemia in the lymph node microenvironmentZhenghao Chen, Helga Simon-Molas, Gaspard Cretenet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2016
The Dual Syk/JAK Inhibitor Cerdulatinib Antagonizes B-cell Receptor and Microenvironmental Signaling in Chronic Lymphocytic LeukemiaMatthew D Blunt, Stefan Koehrer, Rachel C Dobson, et al.
Blood|May 10, 2015
The PI3K/mTOR inhibitor PF-04691502 induces apoptosis and inhibits microenvironmental signaling in CLL and the Eµ-TCL1 mouse modelMatthew D Blunt, Matthew J Carter, Marta Larrayoz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2018
Target-Based Screening against eIF4A1 Reveals the Marine Natural Product Elatol as a Novel Inhibitor of Translation Initiation with <i>In Vivo</i> Antitumor ActivityTara L Peters, Joseph Tillotson, Alison M Yeomans, et al.
Pageof 13